CTRI/2024/07/070210尚未招募Unknown
Post approval observational study for the assessment of effectiveness and safety of once a daily sustained release formulation of BRivarACetam in drug rEsisTance focal onset epilepsy - BRACkET
Torrent Pharmaceuticals Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Male or female patients with:
- •1. Partial onset seizures in patients 16 years of age and older
- •2. Patients diagnosed with epilepsy and treated with Brivaracetam SR tablets
排除标准
- •Hypersensitive to Brivaracetam SR tablets or any of the ingredients in medicine
研究者
相似试验
尚未招募
Unknown
To evaluate the efficacy and safety assessment of Nicorandil in ASCVD with AnginaCTRI/2024/01/061624Torrent Pharmaceutical Ltd
尚未招募
Unknown
A study on safety and effectiveness of Azelnidipine and Telmisartan in management of Diabetic Hypertension.CTRI/2024/07/071061Torrent Pharmaceuticals Ltd.
尚未招募
4 期
To assess safety and effectiveness of Sitagliptin, Glimepiride, and Metformin for diabetes patients in India.CTRI/2024/03/064004Torrent Pharmaceuticals Ltd
已完成
不适用
Prospective Observational Post-Authorisation Study on Fresh-transfer and Freeze-all treatments of ART patients undergoing controlled ovarian stimulation with Follitropin alfa (Bemfola®)DRKS00022943GEDEON RICHTER PHARMA GmbH956
尚未招募
不适用
Study to check the safety and effectiveness of Sitagliptin and Dapagliflozin combination in Type 2 Diabetes patients with heart problemsCTRI/2022/09/045218Torrent Pharmaceuticals Ltd